More Sensitivity Analysis of Share 35, Human Immunodeficiency Virus Co-infection, Delist, Hospital Cost on Cost Effectiveness of Direct-Acting Antiviral Agents for Liver Transplant Hepatitis C Virus Patients
- PMID: 28826914
- DOI: 10.1016/j.cgh.2017.07.043
More Sensitivity Analysis of Share 35, Human Immunodeficiency Virus Co-infection, Delist, Hospital Cost on Cost Effectiveness of Direct-Acting Antiviral Agents for Liver Transplant Hepatitis C Virus Patients
Comment in
-
Reply.Clin Gastroenterol Hepatol. 2017 Dec;15(12):1981. doi: 10.1016/j.cgh.2017.08.030. Epub 2017 Aug 31. Clin Gastroenterol Hepatol. 2017. PMID: 28864272 No abstract available.
Comment on
-
Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals.Clin Gastroenterol Hepatol. 2018 Jan;16(1):115-122.e10. doi: 10.1016/j.cgh.2017.06.024. Epub 2017 Jun 17. Clin Gastroenterol Hepatol. 2018. PMID: 28634131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
